Cardiac health in patients with hepatitis B virus-related cirrhosis

被引:9
|
作者
Yuan, Wei [1 ]
Lu, Hong-Zhou [2 ]
Mei, Xue [1 ]
Zhang, Yu-Yi [1 ]
Zhang, Zheng-Guo [1 ]
Zou, Ying [1 ]
Wang, Jie-Fei [1 ]
Qian, Zhi-Ping [1 ]
Guo, Hong-Ying [1 ]
机构
[1] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Liver Intens Care Unit, 2901 Caolang Rd, Shanghai 201508, Peoples R China
[2] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Infect Dis, Shanghai, Peoples R China
关键词
cardiac health; cirrhotic cardiomyopathy; hepatitis B virus; liver cirrhosis; HEART-RATE-VARIABILITY; LIVER-CIRRHOSIS; INTERVAL PROLONGATION; GLOBAL EPIDEMIOLOGY; QT INTERVAL; ASSOCIATION; GUIDELINES; SEVERITY; FIBROSIS; FAILURE;
D O I
10.1097/MD.0000000000014961
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Not only alcoholic cirrhosis related to cardiac dysfunction, cirrhosis caused by nonalcoholic etiology including hepatitis B virus (HBV) infection also related to impaired cardiac health. The aims of present study were to perform a noninvasive evaluation of cardiac function and to evaluate exercise performance in HBV related cirrhotic patients without typical symptoms of cardiac disease. Seventy-nine HBV related cirrhotic patients and 103 matched subjects without a previous history of cardiac involvement were recruited. Clinical examination and cardiac health evaluation were performed. The incidence, risk factors of cardiac dysfunction and exercise tolerance were investigated. A correlation between QTc interval and model for end-stage liver disease score (R=0.239, P=.018) was detected, however, the connection between QTc prolongation and the severity of liver disease was uncertain. Patients with HBV related cirrhosis had a tendency toward left ventricular wall thickening (P=.007). Forty-one patients (51.90%) were in accordance with the definition of cirrhotic cardiomyopathy, and a significant increase in the incidence of cardiac diastolic dysfunction (CDD) could be found with increasing Child-Pugh grade (P=.004). HBV related cirrhotic patients with CDD had a higher level of pro-brain natriuretic peptide (P=.025), international normalized ratio (P=.010) Child-Pugh score (P=.020), and a higher proportion of ascites (P<.001). The higher Child-Pugh score (odds ratio=1.662, P=.010) was an independent diagnostic predictor of CDD. The cardiac depression and exercise tolerance also got worse with increasing Child-Pugh score (P<.001). Impaired cardiac health was common in HBV related cirrhotic patients. Cardiogenic factors must be carefully considered in the integral therapy of cirrhosis. Hepatology physicians should lay emphasis on exercise training in daily life.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Gut microbiota dysbiosis in patients with hepatitis B virus-related cirrhosis
    Shu, Wu
    Shanjian, Chen
    Jinpiao, Lin
    Qishui, Ou
    [J]. ANNALS OF HEPATOLOGY, 2022, 27 (02)
  • [2] Entecavir for the treatment of patients with hepatitis B virus-related decompensated cirrhosis
    Sadler, Matthew D.
    Coffin, Carla S.
    Lee, Samuel S.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (10) : 1363 - 1369
  • [3] The effect of entecavir on Hepatitis B virus-related cirrhosis
    Feng, Lei
    Chen, Yong-Jun
    Tang, Yi
    Xu, Jian-Yu
    Fan, Jing-Yun
    [J]. PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2012, 28 (05) : 921 - 924
  • [4] Management of the patient with hepatitis B virus-related cirrhosis
    Perrillo, RP
    [J]. JOURNAL OF HEPATOLOGY, 2003, 39 : S177 - S180
  • [5] Efficacy of combined therapy in patients with hepatitis B virus-related decompensated cirrhosis
    Guo-Cai Lv
    Jin-Mei Yao
    Yi-Da Yang
    Lin Zheng
    Ji-Fang Sheng
    Yu Chen
    Lan-Juan Li
    [J]. World Journal of Gastroenterology, 2013, (22) : 3481 - 3486
  • [6] Efficacy of lamivudine treatment in Japanese patients with hepatitis B virus-related cirrhosis
    Hiromi Ooga
    Fumitaka Suzuki
    Akihito Tsubota
    Yasuji Arase
    Yoshiyuki Suzuki
    Norio Akuta
    Hitomi Sezaki
    Tetsuya Hosaka
    Takashi Someya
    Masahiro Kobayashi
    Satoshi Saitoh
    Kenji Ikeda
    Mariko Kobayashi
    Marie Matsuda
    Junko Satoh
    Hiromitsu Kumada
    [J]. Journal of Gastroenterology, 2004, 39 : 1078 - 1084
  • [7] Efficacy of lamivudine treatment in Japanese patients with hepatitis B virus-related cirrhosis
    Ooga, H
    Suzuki, F
    Tsubota, A
    Arase, Y
    Suzuki, Y
    Akuta, N
    Sezaki, H
    Hosaka, T
    Someya, T
    Kobayashi, M
    Saitoh, S
    Ikeda, K
    Kobayashi, M
    Matsuda, M
    Satoh, J
    Kumada, H
    [J]. JOURNAL OF GASTROENTEROLOGY, 2004, 39 (11) : 1078 - 1084
  • [8] Efficacy of combined therapy in patients with hepatitis B virus-related decompensated cirrhosis
    Lv, Guo-Cai
    Yao, Jin-Mei
    Yang, Yi-Da
    Zheng, Lin
    Sheng, Ji-Fang
    Chen, Yu
    Li, Lan-Juan
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (22) : 3481 - 3486
  • [9] Hepatitis B virus-related cirrhosis: Natural history and treatment
    Chu, CM
    Liaw, YF
    [J]. SEMINARS IN LIVER DISEASE, 2006, 26 (02) : 142 - 152
  • [10] Antiviral therapy of decompensated hepatitis B virus-related cirrhosis
    Chen Guang-cheng
    Yu Tao
    Huang Kai-hong
    Chen Qi-kui
    [J]. CHINESE MEDICAL JOURNAL, 2012, 125 (02) : 373 - 377